Theralase Technologies Inc. V.TLT

90 and 180 day CR rates 4Q2020/Quarterly news letter

[floatinketucky]

4Q2020 out of 14 patients 5 removed from the study. 

90 DAY ASSESSMENT

Complete Response 34%
3 patients

To be determined 11%
1 patient

Partial Response 22%
2 Patients

Non Responder 33%
3 Patients


180 Day Assessment

Complete Response 45%
4 patients

to be determined 22%
2 patient

Partial Response 22%
2 Patients

Non Responder 11%
1 Patients

https://theralase.com/wp-content/uploads/2021/01/Quarterly-Newsletter-4Q2020.pdf

[Oilminerdeluxe]

With the correct dosagaes, well, we should see even better results next time we get an update.

[floatinketucky]

From the 90 day CR to the 180 day CR we picked up 1 patient.  In the 180 Day Assment of 9 patients 4 are CR and 5 are not.  If 2 of the 5 flip to CR we will be at 67%

[Oilminerdeluxe]

67%, i can see myself salivating if that occurs. You never know. And if so, things 'should' turn even better of no other mishap arrives. Unjinx !!

[floatinketucky]

Well from the 90 to the 180 we increased the TBD. Hopefully that does not increace again.   LOL

[floatinketucky]

It would be funny if the company already knew they had it so Rodger didn't buy.

[floatinketucky]

Shawn Shirazi went on to say, "In a 3Q2019 conference call with the FDA, it was discussed and agreed between the FDA and the Company, that Theralase would potentially be eligible for Fast Track Approval ("FTA") post receipt of the FDA IND authorization, based on the clinical study data collected to date. It was further discussed and agreed that Theralase would potentially be

[floatinketucky]